Galaxy TherapeuticsInnovative Neurovascular Devices
Over 6 million Americans suffer from unruptured cerebral aneurysms. Unfortunately, the devices used to treat cerebral aneurysms have just a 50% success rate.
Galaxy Therapeutics is developing a treatment device that will solve these shortcomings.
Easy deployment & fluoroscopic visualization
Improved conformation to aneurysm
Extended treatment for shallow or large aneurysms
Our team has decades of industry experience
Osama Zaidat, MD, MS
President
Dr. Zaidat has led multiple FDA clinical studies, with IDE, PMA, HDE, and 510k experience
Edgard Pereira, MD, MBA
Secretary
Dr. Pereira is an Endovascular Neuro-Interventionalist with over 20 years of experience.
Thomas Wolfe, MD
Vice President
Dr. Wolfe is an Endovascular Neuro-Interventionalist with more than 15 years experience treating strokes.
Aamir Badruddin, MD, MBA
CFO
Dr. Badruddin has over 10 years of experience in Stroke and Endovascular Neurology.